We are live on ! Find out more
DA

DCF Advisers Portfolio holdings

AUM $375M
1-Year Est. Return 72.65%
This Fund
S&P 500
This Quarter Est. Return
+0.57%
1 Year Est. Return
+72.65%
3 Year Est. Return
+156.29%
5 Year Est. Return
+218.72%
10 Year Est. Return
–
AUM
$209M
AUM Growth
+$2.2M
Cap. Flow
+$7.11M
Cap. Flow %
3.4%
Top 10 Hldgs %
41.25%
Holding
111
New
24
Increased
26
Reduced
21
Closed
25

Top Buys

Rank Stock Value
1
ET icon
Energy Transfer Partners
ET
+$5.85M
2
BABA icon
Alibaba
BABA
+$4.47M
3
UBER icon
Uber
UBER
+$3.6M
4
AZN icon
AstraZeneca
AZN
+$3.31M
5
CSCO icon
Cisco
CSCO
+$2.15M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$12M
2
ABBV icon
AbbVie
ABBV
+$4.03M
3
ARGX icon
argenx
ARGX
+$3.57M
4
IWM icon
iShares Russell 2000 ETF
IWM
+$1.68M
5
TPB icon
Turning Point Brands
TPB
+$1.45M

Sector Composition

Rank Sector Weight
1 Healthcare 31%
2 Technology 21%
3 Consumer Discretionary 7.5%
4 Communication Services 7.46%
5 Financials 4.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
INCY icon
26
Incyte
INCY
$24.2B
$2.72M 1.3%
45,000
-3,500
-7% -$244K
C icon
27
Citigroup
C
$222B
$2.66M 1.27%
37,500
-7,500
-17% -$572K
TEVA icon
28
Teva Pharmaceuticals
TEVA
$40.8B
$2.63M 1.26%
171,000
+23,500
+16% +$420K
EVO icon
29
Evotec
EVO
$679M
$2.51M 1.2%
751,579
+521,708
+227% +$2.13M
PRTA icon
30
Prothena Corp
PRTA
$425M
$2.41M 1.16%
195,000
+91,500
+88% +$1.29M
GLD icon
31
PUT
SPDR Gold Trust
GLD
$131B
$2.31M 1.1%
+8,000
New +$2.12M
ABBV icon
32
AbbVie
ABBV
$443B
$2.25M 1.08%
10,750
-20,750
-66% -$4.03M
AOD
33
abrdn Total Dynamic Dividend Fund
AOD
$1.11B
$2.23M 1.07%
266,000
+4,500
+2% +$38.8K
BNED icon
34
Barnes & Noble Education
BNED
$431M
$2.16M 1.03%
205,443
+29,730
+17% +$307K
XNCR icon
35
Xencor
XNCR
$1.5B
$2.15M 1.03%
202,167
-1,000
-0.5% -$16.5K
AMGN icon
36
Amgen
AMGN
$208B
$2.13M 1.02%
6,825
+1,000
+17% +$295K
ZM icon
37
Zoom
ZM
$28.2B
$2.03M 0.97%
27,500
+5,000
+22% +$398K
AAPL icon
38
Apple
AAPL
$4.54T
$1.78M 0.85%
8,000
– –
JQC icon
39
Nuveen Credit Strategies Income Fund
JQC
$704M
$1.75M 0.84%
324,713
+18,773
+6% +$104K
MRVL icon
40
Marvell Technology
MRVL
$168B
$1.69M 0.81%
27,500
+13,000
+90% +$1.26M
LNSR icon
41
LENSAR
LNSR
$61.5M
$1.63M 0.78%
115,717
-114,338
-50% -$1.31M
URNM icon
42
Sprott Uranium Miners ETF
URNM
$1.76B
$1.38M 0.66%
42,400
– –
PFE icon
43
Pfizer
PFE
$143B
$1.3M 0.62%
51,350
– –
HELP
44
Cybin Inc
HELP
$485M
$1.28M 0.61%
+202,000
New +$1.75M
CRVS icon
45
Corvus Pharmaceuticals
CRVS
$1.12B
$1.27M 0.61%
+400,000
New +$1.88M
B
46
Barrick Mining
B
$61.5B
$1.26M 0.61%
+65,000
New +$1.14M
GDXJ icon
47
VanEck Junior Gold Miners ETF
GDXJ
$6.89B
$1.23M 0.59%
21,500
– –
BHVN icon
48
Biohaven
BHVN
$2.03B
$1.21M 0.58%
50,500
+14,500
+40% +$511K
QCOM icon
49
Qualcomm
QCOM
$155B
$1.19M 0.57%
7,750
+750
+11% +$122K
GM icon
50
General Motors
GM
$80.4B
$1.18M 0.56%
+25,000
New +$1.23M
1
2
3 4

Similar funds

JIC
JRM Investment Counsel Omaha, Nebraska $375M AUM 13.43% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return
AIM
Access Investment Management Atlanta, Georgia $376M AUM 17.2% 1-Year Est. Return
MWM
McMill Wealth Management Norfolk, Nebraska $376M AUM 14.46% 1-Year Est. Return
RCP
RIT Capital Partners London, United Kingdom $374M AUM 25.18% 1-Year Est. Return
HPM
Helix Partners Management New York $374M AUM 136.73% 1-Year Est. Return
CAG
Compass Advisory Group Melville, New York $374M AUM 14.59% 1-Year Est. Return
LWMNY
Landmark Wealth Management (New York) Melville, New York $373M AUM 12.01% 1-Year Est. Return

DCF Advisers's Q1 2025 Portfolio in Review

As of Q1 2025, DCF Advisers held 111 positions worth $209M, up 1.1% from $207M the previous quarter. Its ten largest holdings account for 41% of the portfolio.

DCF Advisers deployed $7.11M of net new capital in Q1 2025, opening 24 new positions and adding to 26 existing holdings. Its largest new stake was Energy Transfer Partners: 300,500 shares worth $5.59M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 35% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Intra-Cellular Therapies Inc., an estimated $12M trimmed.

  • DCF Advisers's largest Q1 2025 buy was Energy Transfer Partners: 300,500 shares worth $5.59M.
  • DCF Advisers added most to Cisco in Q1 2025, an estimated $2.15M increase.
  • DCF Advisers's biggest Q1 2025 reduction was Intra-Cellular Therapies Inc., cutting an estimated $12M.
  • DCF Advisers fully exited Boeing in Q1 2025, selling an estimated $1.24M.
  • DCF Advisers's ten largest holdings make up 41% of its $209M portfolio in Q1 2025.
  • DCF Advisers opened 24 new positions and closed 25 in Q1 2025.
  • DCF Advisers's portfolio value rose 1.1% quarter-over-quarter to $209M.

Based on DCF Advisers's 13F filing for Q1 2025, filed 9 May 2025.